Bioactivation of drugs in the skin: relationship to cutaneous adverse drug reactions

References

• Ademola JI, Wester RC, Maibach HI. (1993). Metabolism of 3-indolylacetic acid during percutaneous absorption in human skin. J Pharm Sci 82:150–154
   PubMed Web of Science ®Google Scholar
• Anderson RJ, Kudlacek PE, Clemens DL. (1998). Sulfation of minoxidil by multiple human cytosolic sulfotransferases. Chem Biol Interact 109:53–67
   PubMed Web of Science ®Google Scholar
• Antonopoulos C, Cumberbatch M, Mee JB, et al. (2008). Il-18 is a key proximal mediator of contact hypersensitivity and allergen-induced langerhans cell migration in murine epidermis. J Leukoc Biol 83:361–367
   PubMed Web of Science ®Google Scholar
• Aust S, Obrist P, Klimpfinger M, et al. (2005). Altered expression of the hormone- and xenobiotic-metabolizing sulfotransferase enzymes 1a2 and 1c1 in malignant breast tissue. Int J Oncol 26:1079–1085
   PubMed Web of Science ®Google Scholar
• Baron JM, Holler D, Schiffer R, et al. (2001). Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol 116:541–548
   PubMed Web of Science ®Google Scholar
• Bell CC, Santoyo Castelazo A, Yang EL, et al. (2013). Oxidative bioactivation of abacavir in subcellular fractions of human antigen presenting cells. Chem Res Toxicol
   Google Scholar
• Ben m'rad M, Leclerc-Mercier S, Blanche P, et al. (2009). Drug-induced hypersensitivity syndrome: Clinical and biologic disease patterns in 24 patients. Medicine 88:131–140
   PubMed Web of Science ®Google Scholar
• Bergstrom MA, Ott H, Carlsson A, et al. (2007). A skin-like cytochrome p450 cocktail activates prohaptens to contact allergenic metabolites. J Invest Dermatol 127:1145–1153
   PubMed Web of Science ®Google Scholar
• Bersoff-Matcha SJ, Miller WC, et al. (2001). Sex differences in nevirapine rash. Clin Infect Dis 32:124–129
   PubMed Web of Science ®Google Scholar
• Blazquez AB, Cuesta J, Mayorga C. (2011). Role of dendritic cells in drug allergy. Curr Opin Allergy Clin Immunol 11:279–284
   PubMed Web of Science ®Google Scholar
• Bronaugh RL, Collier SW, Macpherson SE, Kraeling ME. (1994). Influence of metabolism in skin on dosimetry after topical exposure. Environ Health Perspect 11:71–74
   Google Scholar
• Brookes P, Lawley PD. (1964). Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: Relation between carcinogenic power of hydrocarbons and their binding to deoxyribonucleic acid. Nature 202:781–784
   PubMed Web of Science ®Google Scholar
• Chan LS. (2004). Animal models of human inflammatory skin diseases. Boca Raton: CRC Press LLC
   Google Scholar
• Chapman E, Best MD, Hanson SR, Wong CH. (2004). Sulfotransferases: Structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chem Int Ed Engl 43:3526–3548
   PubMed Web of Science ®Google Scholar
• Chen J, Mannargudi BM, Xu L, Uetrecht J. (2008). Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash. Chem Res Toxicol 21:1862–1870
   PubMed Web of Science ®Google Scholar
• Chen X, Tharmanathan T, Mannargudi B, et al. (2009). A study of the specificity of lymphocytes in nevirapine-induced skin rash. J Pharmacol Exp Ther 331:836–841
   PubMed Web of Science ®Google Scholar
• Chung W-H, Hung S-I, Yang J-Y, et al. (2008). Granulysin is a key mediator for disseminated keratinocyte death in stevens-johnson syndrome and toxic epidermal necrolysis. Nat Med 14:1343–1350
   PubMed Web of Science ®Google Scholar
• Du L, Hoffman SM, Keeney DS. (2004). Epidermal cyp2 family cytochromes p450. Toxicol Appl Pharmacol 195:278–287
   PubMed Web of Science ®Google Scholar
• Gamage N, Barnett A, Hempel N, et al. (2006). Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 90:5–22
   PubMed Web of Science ®Google Scholar
• Girolomoni G, Tessari G, Bos JD. (2006). The skin as an immunologic organ. In: Sarzi-Puttini P, Doria A, Girolomoni G, Kuhn A, Doria A, eds. Series editor: Asherson RA. Handbook of systemic autoimmune diseases, Vol. 5. Elsevier, 3–9
   Google Scholar
• Gomez E, Blanca-Lopez N, Salas M, et al. (2013). Induction of accelerated reactions to amoxicillin by t-cell effector mechanisms. Ann Allergy Asthma Immunol 110:267–273
   PubMed Web of Science ®Google Scholar
• Gotz C, Pfeiffer R, Tigges J, Blatz V, et al. (2012a). Xenobiotic metabolism capacities of human skin in comparison with a 3d epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: Activating enzymes (phase I). Exp Dermatol 21:358–363
   PubMed Web of Science ®Google Scholar
• Gotz C, Pfeiffer R, Tigges J, et al. (2012b). Xenobiotic metabolism capacities of human skin in comparison with a 3d-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: Phase II enzymes. Exp Dermatol 21:364–369
   PubMed Web of Science ®Google Scholar
• Gutowska-Owsiak D, Ogg GS. (2012). The epidermis as an adjuvant. J Invest Dermatol 132:940–948
   PubMed Web of Science ®Google Scholar
• Henri S, Poulin LF, Tamoutounour S, et al. (2010). Cd207+ cd103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of langerhans cells. J Exp Med 207:189–206
   PubMed Web of Science ®Google Scholar
• Hetherington S, McGuirk S, Powell G, et al. (2001). Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. Clin Ther 23:1603–1614
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Edwards RJ, Fritsche E, et al. (2013). Use of human in vitro skin models for accurate and ethical risk assessment: Metabolic considerations. Toxicol Sci 133:209–217
   PubMed Web of Science ®Google Scholar
• Higashi Y, Fuda H, Yanai H, et al. (2004). Expression of cholesterol sulfotransferase (sult2b1b) in human skin and primary cultures of human epidermal keratinocytes. J Invest Dermatol 122:1207–1213
   PubMed Web of Science ®Google Scholar
• Hung S-I, Chung W-H, Liou L-B, et al. (2005). Hla-b*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proce Natl Acad Sci USA 102:4134–4139
   PubMed Web of Science ®Google Scholar
• Hyson C, Sadler M. (1997). Cross sensitivity of skin rashes with antiepileptic drugs. Can J Neurol Sci 24:245–249
   PubMed Web of Science ®Google Scholar
• Illing PT, Vivian JP, Dudek NL, et al. (2012). Immune self-reactivity triggered by drug-modified hla-peptide repertoire. Nature 486:554–558
   PubMed Web of Science ®Google Scholar
• Imai Y, Hayashi N, Yasuda K, et al. (2008). Freshly isolated langerhans cells negatively regulate naive T cell activation in response to peptide antigen through cell-to-cell contact. J Dermatol Sci 51:19–29
   PubMed Web of Science ®Google Scholar
• Jackh C, Fabian E, van Ravenzwaay B, Landsiedel R. (2012). Relevance of xenobiotic enzymes in human skin in vitro models to activate pro-sensitizers. J Immunotoxicol 9:426–438
   PubMed Web of Science ®Google Scholar
• Josephy PD, Mannervik B. (2006). Molecular toxicology. 2nd ed. New York: Oxford University Press
   Google Scholar
• Ju C, Uetrecht JP. (1999). Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate. J Pharmacol Exp Ther 288:51–56
   PubMed Web of Science ®Google Scholar
• Kaplan DH, Igyarto BZ, Gaspari AA. (2012). Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol 12:114–124
   PubMed Web of Science ®Google Scholar
• Khan DA. (2012). Cutaneous drug reactions. J Allergy Clin Immunol 130:1225–1226
   PubMed Web of Science ®Google Scholar
• Klaassen CD. (2008). Toxic responses of the skin in toxicology the basic science of poisons. 7th ed. New York: McGraw-Hill Companies
   Google Scholar
• Krishnaswamy JK, Chu T, Eisenbarth SC. (2013). Beyond pattern recognition: Nod-like receptors in dendritic cells. Trends Immunol 34:224–233
   PubMed Web of Science ®Google Scholar
• Lasser K, Allen P, Woolhandler S, et al. (2002). Timing of new black box warnings and withdrawals for prescription medications. JAMA 287:2215–2220
   PubMed Web of Science ®Google Scholar
• Lu W, Uetrecht JP. (2007). Possible bioactivation pathways of lamotrigine. Drug Metab Dispos 35:1050–1056
   PubMed Web of Science ®Google Scholar
• Lu W, Uetrecht JP. (2008). Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin. Drug Metab Dispos 36:1624–1636
   PubMed Web of Science ®Google Scholar
• Luu-The V, Duche D, Ferraris C, et al. (2009). Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models episkin and full thickness model from episkin. J Steroid Biochem Mol Biol 116:178–186
   PubMed Web of Science ®Google Scholar
• Madison KC. (2003). Barrier function of the skin: “La raison d'etre” of the epidermis. J Invest Dermatol 121:231–241
   PubMed Web of Science ®Google Scholar
• Mallal S, Nolan D, Witt C, et al. (2002). Association between presence of hla-b*5701, hla-dr7, and hla-dq3 and hypersensitivity to hiv-1 reverse-transcriptase inhibitor abacavir. Lancet 359:727–732
   PubMed Web of Science ®Google Scholar
• Mallal S, Phillips E, Carosi G, et al. (2008). Hla-b*5701 screening for hypersensitivity to abacavir. N Engl J Med 358:568–579
   PubMed Web of Science ®Google Scholar
• Martin AM, Nolan D, Gaudieri S, et al. (2004). Predisposition to abacavir hypersensitivity conferred by hla-b*5701 and a haplotypic hsp70-hom variant. Proc Natl Acad Sci USA 101:4180–4185
   PubMed Web of Science ®Google Scholar
• Masson MJ, Collins LA, Pohl LR. (2010). The role of cytokines in the mechanism of adverse drug reactions. Handb Exp Pharmacol 196:195–231
   PubMedGoogle Scholar
• McCormack M, Urban TJ, Shianna KV, et al. (2012). Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions. Pharmacogenomics J 13:399–405
   Google Scholar
• Merad M, Ginhoux F, Collin M. (2008). Origin, homeostasis and function of langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8:935–947
   PubMed Web of Science ®Google Scholar
• Merk H, Jugert F, Bonnekoh B, Mahrle G. (1991). Induction and inhibition of nad(p)h: Quinone reductase in murine and human skin. Skin Pharmacol 4:183–190
   PubMedGoogle Scholar
• Merk HF, Baron JM, Neis MM, et al. (2007). Skin: Major target organ of allergic reactions to small molecular weight compounds. Toxicol Appl Pharmacol 224:313–317
   PubMed Web of Science ®Google Scholar
• Miller EC. (1951). Studies on the formation of protein-bound derivatives of 3,4-benzpyrene in the epidermal fraction of mouse skin. Cancer Res 11:100–108
   PubMed Web of Science ®Google Scholar
• Montannez MI, Mayorga C, Torres MJ, et al. (2011). Synthetic approach to gain insight into antigenic determinants of cephalosporins: In vitro studies of chemical structure-ige molecular recognition relationships. Chem Res Toxicol 24:706–717
   PubMed Web of Science ®Google Scholar
• Moss T, Howes D, Williams FM. (2000). Percutaneous penetration and dermal metabolism of triclosan (2,4,4′-trichloro-2′-hydroxydiphenyl ether). Food Chem Toxicol 38:361–370
   PubMed Web of Science ®Google Scholar
• Naisbitt DJ, Hough SJ, Gill HJ, et al. (1999). Cellular disposition of sulphamethoxazole and its metabolites: Implications for hypersensitivity. Br J Pharmacol 126:1393–1407
   PubMed Web of Science ®Google Scholar
• Nestle FO, Di Meglio P, Qin J-Z, Nickoloff BJ. (2009). Skin immune sentinels in health and disease. Nat Rev Immunol 9:679–691
   PubMed Web of Science ®Google Scholar
• Nickoloff BJ. (2008). Saving the skin from drug-induced detachment. Nat Med 14:1311–1313
   PubMed Web of Science ®Google Scholar
• Oesch F, Fabian E, Oesch-Bartlomowicz B, et al. (2007). Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab Rev 39:659–698
   PubMed Web of Science ®Google Scholar
• Oesch-Bartlomowicz B, Oesch F. (2007). 5.08 – mechanisms of toxification and detoxification which challenge drug candidates and drugs. In: John BT, David JT, eds. Comprehensive medicinal chemistry II. Oxford: Elsevier, 193–214
   Google Scholar
• Park B, Pirmohamed M, Kitteringham N. (1998). Role of drug disposition in drug hypersensitivity: A chemical, molecular, and clinical perspective. Chem Res Toxicol 11:969--988
   PubMed Web of Science ®Google Scholar
• Pichler WJ. (2003). Delayed drug hypersensitivity reactions. Ann Intern Med 139:683–693
   PubMed Web of Science ®Google Scholar
• Pollard RB, Robinson P, Dransfield K. (1998). Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Clin Ther 20:1071–1092
   PubMed Web of Science ®Google Scholar
• Popovic M, Caswell JL, Mannargudi B, et al. (2006). Study of the sequence of events involved in nevirapine-induced skin rash in brown norway rats. Chem Res Toxicol 19:1205–1214
   PubMed Web of Science ®Google Scholar
• Reilly TP, Lash LH, Doll MA, et al. (2000). A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol 114:1164–1173
   PubMed Web of Science ®Google Scholar
• Rolsted K, Kissmeyer A-M, Rist G, Hansen S. (2008). Evaluation of cytochrome p450 activity in vitro, using dermal and hepatic microsomes from four species and two keratinocyte cell lines in culture. Arch of Dermatol Res 300:11–18
   PubMed Web of Science ®Google Scholar
• Roos TC, Jugert FK, Merk HF, Bickers DR. (1998). Retinoid metabolism in the skin. Pharmacol Rev 50:315–333
   PubMed Web of Science ®Google Scholar
• Roujeau JC, Stern RS. (1994). Severe adverse cutaneous reactions to drugs. N Engl J Med 331:1272–1285
   PubMed Web of Science ®Google Scholar
• Roychowdhury S, Svensson C. (2005). Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin. AAPS J 7:E834--E846
   PubMed Web of Science ®Google Scholar
• Saeki M, Saito Y, Nagano M, et al. (2002). Mrna expression of multiple cytochrome p450 isozymes in four types of cultured skin cells. Int Arch Allergy Immunol 127:333–336
   PubMed Web of Science ®Google Scholar
• Sanderson JP, Naisbitt DJ, Park BK. (2006). Role of bioactivation in drug-induced hypersensitivity reactions. AAPS J 8:E55–64
   PubMed Web of Science ®Google Scholar
• Sanderson JP, Naisbitt DJ, Farrell J, et al. (2007). Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J Immunol 178:5533–5542
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ, Medzhitov R. (2009). Learning tolerance while fighting ignorance. Cell 138:416–420
   PubMed Web of Science ®Google Scholar
• Schenten D, Medzhitov R. (2011). The control of adaptive immune responses by the innate immune system. Adv Immunol 109:87–124
   PubMed Web of Science ®Google Scholar
• Sharma AM, Klarskov K, Uetrecht J. (2013a). Nevirapine bioactivation and covalent binding in the skin. Chem Res Toxicol 26:410–421
   PubMed Web of Science ®Google Scholar
• Sharma AM, Li Y, Novalen M, et al. (2012). Bioactivation of nevirapine to a reactive quinone methide: Implications for liver injury. Chem Res Toxicol 25:1708–1719
   PubMed Web of Science ®Google Scholar
• Sharma AM, Novalen M, Tanino T, Uetrecht JP. (2013b). 12-oh-nevirapine sulfate, formed in the skin, is responsible for nevirapine-induced skin rash. Chem Res Toxicol 26:817–827
   PubMed Web of Science ®Google Scholar
• Shenton JM, Popovic M, Chen J, et al. (2005). Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female brown norway rat. Chem Res Toxicol 18:1799–1813
   PubMed Web of Science ®Google Scholar
• Shenton JM, Teranishi M, Abu-Asab MS, et al. (2003). Characterization of a potential animal model of an idiosyncratic drug reaction: Nevirapine-induced skin rash in the rat. Chem Res Toxicol 16:1078–1089
   PubMed Web of Science ®Google Scholar
• Shimada M, Matsuda T, Sato A, et al. (2008). Expression of a skin cholesterol sulfotransferase, st2b2, is a trigger of epidermal cell differentiation. Xenobiotica 38:1487–1499
   PubMed Web of Science ®Google Scholar
• Shimizu C, Fuda H, Yanai H, Strott CA. (2003). Conservation of the hydroxysteroid sulfotransferase sult2b1 gene structure in the mouse: Pre- and postnatal expression, kinetic analysis of isoforms, and comparison with prototypical sult2a1. Endocrinology 144:1186–1193
   PubMed Web of Science ®Google Scholar
• Shiohara T. (2009). Fixed drug eruption: Pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol 9:316–321
   PubMed Web of Science ®Google Scholar
• Singh J, Petter RC, Baillie TA, Whitty A. (2011). The resurgence of covalent drugs. Nat Rev Drug Discov 10:307–317
   PubMed Web of Science ®Google Scholar
• Smith G, Wolf CR, Deeni YY, et al. (2003). Cutaneous expression of cytochrome p450 cyp2s1: Individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361:1336–1343
   PubMed Web of Science ®Google Scholar
• Stutz A, Golenbock DT, Latz E. (2009). Inflammasomes: Too big to miss. J Clin Invest 119:3502–3511
   PubMed Web of Science ®Google Scholar
• Sugita K, Kabashima K, Atarashi K, et al. (2007). Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving langerhans cells and T cells in the skin. Clin Exp Immunol 147:176–183
   PubMed Web of Science ®Google Scholar
• Sutter TR, Tang YM, Hayes CL, et al. (1994). Complete cdna sequence of a human dioxin-inducible mrna identifies a new gene subfamily of cytochrome p450 that maps to chromosome 2. J Biol Chem 269:13092–13099
   PubMed Web of Science ®Google Scholar
• Sutterwala FS, Ogura Y, Szczepanik M, et al. (2006). Critical role for nalp3/cias1/cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24:317–327
   PubMed Web of Science ®Google Scholar
• Svensson CK. (2009). Biotransformation of drugs in human skin. Drug Metab Dispos 37:247–253
   PubMed Web of Science ®Google Scholar
• Swamy M, Jamora C, Havran W, Hayday A. (2010). Epithelial decision makers: In search of the 'epimmunome'. Nat Immunol 11:656–665
   PubMed Web of Science ®Google Scholar
• Uetrecht J, Naisbitt DJ. (2013). Idiosyncratic adverse drug reactions: Current concepts. Pharmacol Rev 65:779–808
   PubMed Web of Science ®Google Scholar
• Uetrecht J, Trager W. (2007). Drug metabolism chemical and enzymatic aspects. 1st ed. New York: Informa Healthcare
   Google Scholar
• Ullrich SE. (2010). Skin immunology and immunotoxicity. In: Charlene AM, ed. Comprehensive toxicology. 2nd edn. Oxford: Elsevier, 217–234
   Google Scholar
• Vaculik C, Schuster C, Bauer W, et al. (2012). Human dermis harbors distinct mesenchymal stromal cell subsets. J Invest Dermatol 132:563–574
   PubMed Web of Science ®Google Scholar
• Van der Aar AM, Sylva-Steenland RM, Bos JD, et al. (2007). Loss of tlr2, tlr4, and tlr5 on langerhans cells abolishes bacterial recognition. J Immunol 178:1986–1990
   PubMed Web of Science ®Google Scholar
• Van der Aar AMG, Picavet DI, Muller FJ, et al. (2013). Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cells. J Invest Dermatol 133:1240–1249
   PubMed Web of Science ®Google Scholar
• Vickers AE, Biggi WA, Dannecker R, Fischer V. (1995). Uptake and metabolism of cyclosporin a and sdz imm 125 in the human in vitro skin2 dermal and barrier function models. Life Sci 57:215–224
   PubMed Web of Science ®Google Scholar
• Vyas PM, Roychowdhury S, Khan FD, et al. (2006a). Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes p450. J Pharmacol Exp Ther 319:488–496
   PubMed Web of Science ®Google Scholar
• Vyas PM, Roychowdhury S, Koukouritaki SB, et al. (2006b). Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: Ii. Expression and role of flavin-containing monooxygenases and peroxidases. J Pharmacol Exp Ther 319:497–505
   PubMed Web of Science ®Google Scholar
• Wang B, Amerio P, Sauder DN. (1999). Role of cytokines in epidermal langerhans cell migration. J Leukoc Biol 66:33–39
   PubMed Web of Science ®Google Scholar
• Wang B, Feliciani C, Howell BG, et al. (2002). Contribution of langerhans cell-derived IL-18 to contact hypersensitivity. J Immunol 168:3303–3308
   PubMed Web of Science ®Google Scholar
• Wang J, Hori K, Ding J, et al. (2011). Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol 226:1265–1273
   PubMed Web of Science ®Google Scholar
• Watanabe H, Gaide O, Petrilli V, et al. (2007). Activation of the il-1[beta]-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 127:1956–1963
   PubMed Web of Science ®Google Scholar
• Watanabe H, Gehrke S, Contassot E, et al. (2008). Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J Immunol 180:5826–5832
   PubMed Web of Science ®Google Scholar
• Wickett RR, Visscher MO. (2006). Structure and function of the epidermal barrier. Am J Infect Control 34:S98-S110
   Web of Science ®Google Scholar